Utility of the CPS + EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy. Marme F, Solbach C, Michel L, Schneeweiss A, et al. Eur J Cancer 2021;153:203-212.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Marme F, Solbach C, Michel L, Schneeweiss A, et al. Utility of the CPS + EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy. Eur J Cancer 2021;153:203-212.
PMID: 34186505